Rochester Medical Completes Acquisition of Laprolan

Loading...
Loading...
Rochester Medical Corporation
ROCM
today announced that it has now completed the previously announced purchase of Laprolan B.V., the former Medical Supplies Division and wholly owned subsidiary of Fornix BioSciences N.V. Under the terms of the purchase agreement the purchase is deemed retroactive to January 1, 2011.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsM&AHealth CareHealth Care Supplies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...